Stories

Mon, 14 Sep 2026

Mon, 14 Sep 2026 Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy

The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025